Cathelicidin Peptides Inhibit Multiply Antibiotic-Resistant Pathogens from Patients with Cystic Fibrosis

Endogenous peptide antibiotics are under investigation as inhaled therapeutic agents for cystic fibrosis (CF) lung disease. The bactericidal activities of five cathelicidin peptides (LL37 [human], CAP18 [rabbit], mCRAMP [mouse], rCRAMP [rat], and SMAP29 [sheep]), three novel alpha-helical peptides d...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Saiman, Lisa, Tabibi, Setareh, Starner, Timothy D., San Gabriel, Pablo, Winokur, Patricia L., Jia, Hong Peng, McCray, Paul B., Tack, Brian F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90740/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11557478/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.10.2838-2844.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!